This study is to check how safe and effective a medicine called CRYSVITA® is for patients in South Korea. CRYSVITA® is a special injection given to people who need it for certain health reasons. To be in the study, participants must already be using CRYSVITA® as per the rules in Korea and need to agree in writing to join. If the patient is a child, their parent or guardian must also agree. 📝
However, some people cannot join the study. For example, if the medicine is not safe for them (contraindicated) or if they want to use it for reasons not approved, they can't participate. Also, those who were part of earlier trials or have been using the drug before this study started are not allowed.
This study helps ensure the medicine is safe for everyone who needs it. 😊
NCT06202027
Kyowa Kirin Korea Co., Ltd.
24 January 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.